Pharmaxis Ltd

Press Releases

2005-December-16	Bronchitol TM European Cystic Fibrosis Study Commences (in PDF)
2005-December-14	U.S. Phase III Aridol Trial Enrols First Patient (in PDF)
2005-November-28	Bronchitol Cystic Fibrosis Dose Finding Study Commences (in PDF)
2005-November-14	Bronchitol Granted Orphan Drug Status in Europe (in PDF)
2005-November-11	Pharmaxis Ltd Completes $87 Million Capital Raising (in PDF)
2005-November-8	Pharmaxis Ltd Announces Pricing of Global Capital Raising (in PDF)
2005-October-28	Pharmaxis Global Fund Raising Approved (in PDF)
2005-September-26	Pharmaxis Ltd Announces Global Capital Raising (in PDF)
2005-September-15	Enrolment Commenced in AridolTM COPD Study (in PDF)
2005-August-31	Bronchitol Cystic Fibrosis Trial Results Positive (in PDF)
2005-August-30	Pharmaxis Opens on NASDAQ National Market (in PDF)
2005-August-23	Pharmaxis Lists ADRs on NASDAQ (in PDF)
2005-July-21	Approval to Begin Canadian Cystic Fibrosis Trial Granted (in PDF)
2005-July-20	US FDA Grants Bronchitol Orphan Drug Status for Treatment of Cystic Fibrosis (in PDF)
2005-May-19	Pharmaxis Applies to Market AridolTM in Europe (in PDF)
2005-May-12	BronchitolTM Approved for Patient Use under the Special Access Scheme (in PDF)
2005-April-29	Cystic Fibrosis Trial Reaches Target Recruitment (in PDF)
2005-March-2	Pharmaxis Expands Senior Management Team (in PDF)
2005-February-23	US FDA Grants Pharmaxis's Bronchitol Orphan Drug Status (in PDF)
2005-February-9	Pharmaxis to Commence UK Phase II Trial for Bronchitol in Cystic Fibrosis (in PDF)
2005-January-18	Pharmaxis Applies for Regulatory Approval to Market Aridol (in PDF)
2017	2017 Press Releases
2016	2016 Press Releases
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases
2006	2006 Press Releases
2004	2004 Press Releases